FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

395814003: Oxaliplatin (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469754018 Oxaliplatin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489455013 Oxaliplatin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
59691000195119 oxaliplatino it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
830031000172112 oxaliplatine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
75031000195113 Oxaliplatin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxaliplatin (substance) Is a Platinum compound true Inferred relationship Some
Oxaliplatin (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Oxaliplatin (substance) Is a complexe métallique comme agent antinéoplasique false Inferred relationship Some
Oxaliplatin (substance) Is a allergène médicamenteux false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing oxaliplatin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oxaliplatin (substance) Inferred relationship Some 1
Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxaliplatin (substance) Inferred relationship Some
Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxaliplatin (substance) Inferred relationship Some
Oxaliplatin 5mg/mL injection solution 50mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxaliplatin (substance) Inferred relationship Some
Oxaliplatin 5mg/mL injection solution 100mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxaliplatin (substance) Inferred relationship Some
Oxaliplatin desensitization therapy (regime/therapy) Using substance (attribute) False Oxaliplatin (substance) Inferred relationship Some 1
Oxaliplatin desensitization therapy (regime/therapy) Using substance (attribute) True Oxaliplatin (substance) Inferred relationship Some 1
Product containing oxaliplatin in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oxaliplatin (substance) Inferred relationship Some 1
Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Oxaliplatin (substance) Inferred relationship Some 1
Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Oxaliplatin (substance) Inferred relationship Some 1
Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Oxaliplatin (substance) Inferred relationship Some 1
Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Oxaliplatin (substance) Inferred relationship Some 1
Oxaliplatin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oxaliplatin (substance) Inferred relationship Some 1
Product containing only oxaliplatin in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oxaliplatin (substance) Inferred relationship Some 1
FOLFIRINOX antineoplastic chemotherapy regimen Direct substance True Oxaliplatin (substance) Inferred relationship Some 3
Product containing precisely oxaliplatin 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Oxaliplatin (substance) Inferred relationship Some 1
Product containing precisely oxaliplatin 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Oxaliplatin (substance) Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start